v3.26.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
NET SALES $ 675,443,125 $ 576,773,090
COST OF GOODS SOLD 446,816,212 385,039,503
Gross profit 228,626,913 191,733,587
OPERATING EXPENSES:    
Engineering, research and development 51,652,619 45,924,364
Selling, general & administrative 49,791,834 29,933,005
Impairment charges (Note 3) 2,800,000 0
Severance expense 722,541 2,889,112
Total operating expenses 104,966,994 78,746,481
Income from operations 123,659,919 112,987,106
OTHER (LOSS) INCOME    
Investment (loss) income, net (87,371) 4,874,855
Other, net (5,524,986) (4,234,379)
Total other (loss) income, net (5,612,357) 640,476
INCOME BEFORE PROVISION FOR INCOME TAXES 118,047,562 113,627,582
PROVISION FOR INCOME TAXES 19,626,503 18,753,537
NET INCOME 98,421,059 94,874,045
Less: Net loss attributable to non-controlling interests (34,084) 0
NET INCOME ATTRIBUTABLE TO GENTEX CORPORATION $ 98,455,143 $ 94,874,045
EARNINGS PER SHARE ATTRIBUTABLE TO GENTEX CORPORATION:    
Basic (in dollars per share) [1] $ 0.46 $ 0.42
Diluted (in dollars per share) [1] 0.46 0.42
Cash Dividends Declared per Share (in dollars per share) $ 0.120 $ 0.120
[1]
(1) Earnings Per Share has been adjusted to exclude the portion of net income allocated to participating securities as a result of share-based payment awards.